
Long-acting erythropoiesis agents can help save resources
(HealthDay)—Switching from short- to long-acting erythropoiesis-stimulating agents (ESAs) in patients undergoing hemodialysis (HD) leads to a large reduction in time and subsequent costs, according to a study published ...
Sep 21, 2017
0
0